Acutaas Chemicals AI Stock Analysis
Want to see IN:ACUTAAS full AI Analyst Report?
Acutaas Chemicals (ACUTAAS) AI Stock Analysis
Acutaas Chemicals
(NSE:ACUTAAS)
Strong profitability, revenue growth, balance-sheet quality, and technical momentum drive the score. The primary constraints are persistently negative free cash flow and an elevated P/E ratio.
Acutaas Chemicals (ACUTAAS) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 330.69B
- Dividend Yield
- 0.06%
- Average Volume (3M)
- 36.34K
- Price to Earnings (P/E)
- 75.6
- Beta (1Y)
- 0.99
- Revenue Growth
- 45.18%
- EPS Growth
- 96.07%
- Country
- India
- Employees
- 1,007
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Acutaas Chemicals Business Overview & Revenue Model
Company Description
Based in Surat, India, Acutaas Chemicals Limited, founded in 2004, is engaged in the development, production, and global distribution of pharmaceutical intermediates. These crucial compounds are utilized in both regulated and generic active pharmaceu...
Acutaas Chemicals Financial Statement Overview
Summary
Strong profitability and revenue growth, improving returns, and minimal leverage support the score. However, persistently negative free cash flow and capital intensity are material weaknesses.
Income Statement
88Very PositiveBalance Sheet
82Very PositiveCash Flow
52Neutral| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.97B | 13.39B | 7.17B | 5.18B | 3.41B | 2.40B |
| Gross Profit | 5.17B | 6.20B | 2.63B | 1.94B | 1.22B | 776.58M |
| EBITDA | 3.02B | 4.80B | 1.04B | 1.08B | 811.14M | 438.14M |
| Net Income | 2.24B | 3.56B | 427.73M | 719.46M | 539.99M | 274.70M |
Balance Sheet | ||||||
| Total Assets | 16.96B | 19.84B | 10.96B | 6.59B | 4.13B | 2.32B |
| Cash, Cash Equivalents and Short-Term Investments | 2.41B | 2.25B | 533.12M | 615.46M | 26.85M | 38.22M |
| Total Debt | 83.49M | 355.96M | 2.17B | 8.44M | 1.37B | 594.20M |
| Total Liabilities | 2.57B | 2.73B | 4.13B | 1.37B | 2.46B | 1.20B |
| Stockholders Equity | 14.14B | 16.54B | 6.74B | 5.22B | 1.67B | 1.12B |
Cash Flow | ||||||
| Free Cash Flow | -46.49M | -285.38M | -1.56B | -424.18M | -794.33M | 54.71M |
| Operating Cash Flow | 1.37B | 2.99B | 1.25B | -86.60M | 271.45M | 270.77M |
| Investing Cash Flow | -1.40B | -2.74B | -3.68B | -1.24B | -1.00B | -239.44M |
| Financing Cash Flow | -91.38M | 53.74M | 2.39B | 1.40B | 721.08M | 1.94M |
Acutaas Chemicals Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ACUTAAS, the sentiment is Positive. The current price of 4042.95 is above the 20-day moving average (MA) of 3645.16, above the 50-day MA of 3399.01, and above the 200-day MA of 2914.98, indicating a bullish trend. The MACD of 186.35 indicates Negative momentum. The RSI at 68.82 is Neutral, neither overbought nor oversold. The STOCH value of 71.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:ACUTAAS.
Acutaas Chemicals Peers Comparison
Overall Rating
IN:ACUTAAS74Outperform
IN:VINATIORGA73Outperform
IN:AETHER71Outperform
IN:ATUL68Neutral
IN:ANURAS63Neutral
IN:AARTIIND47Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 74Outperform | INR 331.00B | 75.60 | ― | 0.06% | 45.18% | 96.07% | |
| 73Outperform | INR 115.82B | 28.36 | ― | 0.76% | 10.98% | -5.48% | |
| 71Outperform | INR 222.43B | 89.38 | ― | ― | 30.76% | 28.12% | |
| 68Neutral | INR 152.11B | 19.71 | ― | 0.58% | 18.15% | 42.38% | |
| 63Neutral | INR 148.26B | 71.44 | ― | 0.11% | 23.80% | 16.11% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 47Neutral | INR 174.79B | 29.53 | ― | 0.21% | 39.85% | 103.71% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:ACUTAAS | Acutaas Chemicals Ltd | 4042.95 | 2333.83 | 136.55% | |
| IN:AARTIIND | AARTI Industries Ltd | 481.85 | 87.48 | 22.18% | |
| IN:AETHER | Aether Industries Ltd. | 1675.75 | 828.30 | 97.74% | |
| IN:ANURAS | Anupam Rasayan India Ltd. | 1302.25 | 218.18 | 20.13% | |
| IN:ATUL | Atul Limited | 5166.40 | -819.40 | -13.69% | |
| IN:VINATIORGA | Vinati Organics Limited | 1117.25 | -548.76 | -32.94% |
Acutaas Chemicals Corporate Events
Acutaas Chemicals Publishes Q2 and Half-Year 2026 Investor Presentation
Acutaas Chemicals Limited has released an investor presentation detailing its financial results for the second quarter and half year ended September 30, 2026, along with updates on other business matters. The presentation, published in compliance wit...
Acutaas Chemicals Sets Record Date for 50% Final Dividend
Acutaas Chemicals Limited has set 17 September 2026 as the record date to determine shareholders eligible to receive a proposed final dividend for the financial year 2025-26. The company plans a payout of Rs. 2.50 per fully paid equity share of face...
Acutaas Chemicals Outlines TDS Rules on Proposed FY26 Final Dividend
Acutaas Chemicals has informed shareholders that its board has recommended a final dividend of Rs 2.50 per equity share with a face value of Re 5 for FY 2025-26, subject to approval at the 19th Annual General Meeting on 24 September 2026. The dividen...
Acutaas opens South Korean semiconductor materials plant via Indichem
Acutaas Chemicals has inaugurated a semiconductor materials plant in Gongju, South Korea, via its step-down subsidiary Indichem Inc., completing the state-of-the-art facility just eleven months after groundbreaking. The plant sits on a 16,513.7 sq. m...
Acutaas Chemicals Publishes AGM Notice to Meet SEBI Disclosure Rules
Acutaas Chemicals Limited has notified exchanges that it has published newspaper advertisements regarding its 19th Annual General Meeting, scheduled for September 24, 2026 at 11:30 a.m. IST. The notices appeared in the Financial Express All India Eng...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 30, 2026
